Genexine said Friday that the company expects its Covid-19 vaccine candidate, GX-19N, to prevent infection for a long time as it uses T cell immune response instead of antibodies.GX-19N, a DNA vaccine, is a next-generation vaccine with nucleocapsid antibody added to the existing spike protein protec
Sanofi’s Dupixent (dupilumab), a severe atopic dermatitis (AD) treatment covered by health insurance in people aged 18 or more, should become reimbursable for adolescents, too, a petition on Cheong Wa Dae said.Dupixent is the only biologic agent that can treat severe AD. In addition, it proved thera
JW Pharmaceutical said that it would cooperate with Syntekabio in developing innovative new drugs based on artificial intelligence.Under the accord, the two companies will expand the scope of existing joint research to discover first-in-class candidate materials that target specific disease-causing
Genome & Company said that it would build a large-scale microbiome production facility in Fishers City, Indiana, U.S., through its local offshoot, List Biotherapeutics.The company established List Biotherapeutics in October last year. Biotherapeutics plans to build a large-scale microbiome productio
Ildong Pharmaceutical said Wednesday it has decided to jointly develop S-217622, a candidate material for oral Covid-19 treatment, with Shionogi Pharmaceutical, a Japanese drugmaker.The drug candidate, developed by Shionogi, is a substance developed for treating Covid-19 orally by taking the drug
COREE Company, a member of Hanmi Science Consortium, has signed a strategic partnership agreement with Infini Fluidic of the U.S. to develop a new method in the microfluidic process producing mRNA vaccine lipid nanoparticle structures.Hanmi Science CEO Lim Jong-yoon also serves as the president of C
BioLeaders said its Covid-19 treatment candidate under joint development with the Korea Mouse Phenotyping Center has shown effective results against the Delta variant in a recent study.The company also conducted a secondary evaluation of the candidate drug’s efficacy at Seoul National University Bun
Cellid, one of the local developers of a homegrown Covid-19 vaccine, updated its plan for a local, late-stage trial.“Our latest plan for a phase 2b trial benchmarked Janssen’s discussion for a booster shot. We have yet to confirm two doses of the vaccine, but this is one of the many possibilities to
Yuhan Corp. said it received 11.8 billion won ($9.97 million) of milestone payment as its non-alcoholic steatohepatitis (NASH) therapy licensed out to Boehringer Ingelheim entered the global phase 1 trial.Boehringer Ingelheim has paid Yuhan a total of $50 million as milestone payments since it signe
Voronoi said it has licensed out VRN08, a monopolar spindle 1 (MPS1)-targeted solid cancer treatment, to Pyramid Biosciences, a U.S. biotech company.Under the accord, Voronoi will receive up to a total of $846 million in milestone payments from Pyramid Biosciences. However, the company did not unvei
Korea Pharma said it has concluded a deal to receive the transfer of production technology of iron deficiency anemia therapy, Accrufer (ingredient: ferric maltol), from the U.K.-based Shield Therapeutics.On Tuesday, shield Therapeutics Vice Presidents David Childs and Jackie Mitchell visited Korea P
AstraZeneca (AZ) decided to team up with Moderna, a rival Covid-19 vaccine maker, to develop a new treatment for heart failure.AZ’s investigational drug with Moderna’s mRNA technology, which can be injected directly into a patient’s heart, showed a potential to treat heart failure by restoring damag
SK said it plans to sign an exclusive contract by this year-end to invest in The Center for Breakthrough Medicines (CBM), a Philadelphia-based contract development and manufacturing organization (CDMO) specializing in gene and cell therapies.SK expects to emerge as a leading gene and cell therapy CM
Seegene said it has set up Seegene Colombia S.A.S. in Bogota, Colombia, to speed its advance to the Latin American market.It is Seegene’s eighth foreign branch, following those in the U.S., Germany, Italy, the Middle East, Brazil, Canada, and Mexico.Colombia has the third-largest population of 50 mi
SK Bioscience said it has submitted a product approval application to the Ministry of Food and Drug Safety for NVX-CoV2373, a Covid-19 vaccine developed by Novavax.The approval of NVX-CoV2373, administered in 0.5-ml dose to the muscle twice at 21-day intervals, will undergo a review by an expert adv
Pharma Research Bio, which plans to fight the Ministry of Food and Drug Safety’s decision to revoke the license of its botulinum toxin ReNTox, released materials to the media that were slightly different from the truth, industry sources said.The company used vague expressions in the materials regard
Chong Kun Dang said its Indonesian joint venture CKD OTTO signed an export agreement worth $32 million with Saidal, the largest state-run pharmaceutical company in Algeria.Under the accord, CKD OTTO will ship anticancer injections produced at its Indonesian plant to Algeria for the next five years u
Korean pharmaceutical companies are using metaverse, a convergence of virtual and physical space, to actively communicate with newcomers of the “MZ generation.”MZ generation, or millennials and Generation Z, refers to people born between 1980 and 1994 (millennials) and between 1995 and 2004 (Generat
Following Medytox, Hugel and Pharma Research Bio have encountered a crisis, as the government is revoking their manufacturing licenses of botulinum toxin (BTX) products for violating certification and shipping regulations, industry insiders said Friday.A fierce legal battle is going on over whether
Celltrion said that the European Medicines Agency’s (EMA) Committee for Human Medical Products (CHMP) issued a positive scientific opinion on Regkirona, a Covid-19 treatment.According to Celltrion, Regkirona and Roche’s Ronapreve are the first monoclonal antibody medicines to receive a positive opin